HIV Medicine

Cover image for Vol. 19 Issue 1

Edited By: Brian Gazzard and Jens Lundgren

Impact Factor: 3.257

ISI Journal Citation Reports © Ranking: 2016: 26/84 (Infectious Diseases)

Online ISSN: 1468-1293

Most Accessed


The 10 most downloaded papers published in 2016

The role of tenofovir alafenamide in future HIV management
A Antela, C Aguiar, J Compston, BM Hendry, M Boffito, P Mallon, V Pourcher-Martinez and G Di Perri

Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy
M Younas, C Psomas, J Reynes and P Corbeau

Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens
F Raffi, S Esser, G Nunnari, I Pérez-Valero and L Waters

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
Duncan Churchill, Laura Waters, Nadia Ahmed, Brian Angus, Marta Boffito, Mark Bower, David Dunn, Simon Edwards, Carol Emerson, Sarah Fidler, Martin Fisher, Rob Horne, Saye Khoo, Clifford Leen, Nicola Mackie, Neal Marshall, Fernando Monteiro, Mark Nelson, Chloe Orkin, Adrian Palfreeman, Sarah Pett, Andrew Phillips, Frank Post, Anton Pozniak, Iain Reeves, Caroline Sabin, Roy Trevelion, John Walsh, Ed Wilkins, Ian Williams and Alan Winston

Frequency of HIV testing among gay and bisexual men in the UK: implications for HIV prevention
LM McDaid, A Aghaizu, J Frankis, J Riddell, A Nardone, D Mercey, AM Johnson, GJ Hart and P Flowers

Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials
JR Arribas, P-M Girard, N Paton, A Winston, A-G Marcelin, D Elbirt, A Hill and MB Hadacek

Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons
L Ryom, C Boesecke, V Gisler, C Manzardo, JK Rockstroh, M Puoti, H Furrer, JM Miro, JM Gatell, A Pozniak, G Behrens, M Battegay, JD Lundgren and on behalf of the EACS Governing Board

Late presentation to HIV testing is overestimated when based on the consensus definition
A Sasse, E Florence, A Pharris, S De Wit, P Lacor, D Van Beckhoven, J Deblonde, M-L Delforge, K Fransen, J-C Goffard, J-C Legrand, M Moutschen, D Piérard, J Ruelle, D Vaira, B Vandercam, M Van Ranst, E Van Wijngaerden, L Vandekerckhove, C Verhofstede and for the Belgian Research AIDS & HIV Consortium (BREACH)

HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review
CT Lambert, PB Sandesara, B Hirsh, LJ Shaw, W Lewis, AA Quyyumi, RF Schinazi, WS Post and L Sperling

British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015
Prof Anna Maria Geretti, Dr Gary Brook, Ms Claire Cameron, Dr David Chadwick, Prof Neil French, Prof Robert Heyderman, Dr Antonia Ho, Dr Michael Hunter, Dr Shamez Ladhani, Dr Mark Lawton, Dr Eithne MacMahon, Dr John McSorley, Dr Anton Pozniak and Dr Alison Rodger


The 10 most downloaded papers published in 2015

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial
The INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group

Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
JD Baxter, D Dunn, E White, S Sharma, AM Geretti, MJ Kozal, MA Johnson, S Jacoby, JM Llibre, J Lundgren and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group

Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
A Carr, B Grund, J Neuhaus, A Schwartz, JI Bernardino, D White, S Badel-Faesen, A Avihingsanon, K Ensrud, J Hoy and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients
C Cooper, KC Rollet-Kurhajec, J Young, C Vasquez, M Tyndall, J Gill, N Pick, S Walmsley, MB Klein and the Canadian Co-infection Cohort Study Investigators

Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
J Grarup, C Rappoport, NW Engen, C Carey, F Hudson, E Denning, S Sharma, E Florence, MJ Vjecha and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group

Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
AR Lifson, GA Grandits, EM Gardner, MJ Wolff, P Pulik, I Williams, WJ Burman and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group

Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
N Geffen, P Aagaard, GM Corbelli, M Meulbroek, D Peavy, C Rappoport, S Schwarze, S Collins and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Community Advisory Board

Monitoring of kidney function in HIV-positive patients
JC Yombi, R Jones, A Pozniak, J-M Hougardy and FA Post

Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
EJ Wright, B Grund, LA Cysique, KR Robertson, BJ Brew, G Collins, JC Shlay, A Winston, TRH Read, RW Price and for the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group

Increased costs of HIV care associated with aging in an HIV-infected population
HB Krentz and MJ Gill


The 10 most downloaded papers published in 2014

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults
N Clumeck, A Pozniak, F Raffi and the EACS Executive Committee

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)
Dr Ian Williams, Dr Duncan Churchill, Prof Jane Anderson et al.

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults
JK Rockstroh, S Bhagani, Y Benhamou et al.

British HIV Association guidelines for HIV-associated malignancies 2014
Prof Mark Bower, Dr A Palfreeman, Dr Maryam Alfa-Wali et al.

Pregnancy and HIV transmission among HIV-discordant couples in a clinical trial in Kisumu, Kenya
SG Brubaker, EA Bukusi, J Odoyo, J Achando, A Okumu, CR Cohen

British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011
D Asboe, C Aitken, M Boffito et al.

British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013
Writing Group, Dr Ed Wilkins, Dr Mark Nelson et al.

The psychosocial and health care needs of HIV-positive people in the United Kingdom: a review
G Green and R Smith

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
BG Gazzard

Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature
MM Foisy, EMK Yakiwchuk, Chiu, AE Singh

SEARCH

SEARCH BY CITATION